Literature DB >> 20596796

Toll-like receptors and lupus nephritis.

Fabrizio Conti1, Francesca Romana Spinelli, Cristiano Alessandri, Guido Valesini.   

Abstract

A variety of immune mechanisms, both humoral and cellular, are involved in the onset and amplification of the inflammatory response in lupus nephritis (LN). Accumulating evidence substantiates the view that innate immunity pathways may also amplify inflammatory reactions within the kidneys. Toll-like receptors (TLRs) are essential modulators of the innate immune response thanks to their ability to rocognize conserved molecular patterns that are microbe specific and other danger signals. Their recognition of endogenous molecules released from injured cells may also contribute to renal inflammation. Studies conducted in vivo and in vitro provide experimental evidence for the functional role of TLRs in LN. Intriguingly, these data suggest that pharmacological TLR signal suppression could be a useful approach to the treatment of systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20596796     DOI: 10.1007/s12016-010-8208-0

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  49 in total

Review 1.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

Authors:  Terry K Means; Eicke Latz; Fumitaka Hayashi; Mandakolathur R Murali; Douglas T Golenbock; Andrew D Luster
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.

Authors:  Rahul D Pawar; Prashant S Patole; Andreas Ellwart; Maciej Lech; Stephan Segerer; Detlef Schlondorff; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2006-11-02       Impact factor: 10.121

4.  Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.

Authors:  Eva D Papadimitraki; Christianna Choulaki; Eleni Koutala; George Bertsias; Christos Tsatsanis; Irini Gergianaki; Amalia Raptopoulou; Heraklis D Kritikos; Clio Mamalaki; Prodromos Sidiropoulos; Dimitrios T Boumpas
Journal:  Arthritis Rheum       Date:  2006-11

5.  Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.

Authors:  Hans-Joachim Anders; Volker Vielhauer; Vaclav Eis; Yvonne Linde; Matthias Kretzler; Guillermo Perez de Lema; Frank Strutz; Stefan Bauer; Mark Rutz; Hermann Wagner; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  FASEB J       Date:  2004-01-20       Impact factor: 5.191

6.  Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.

Authors:  Kareem L Graham; Lowen Y Lee; John P Higgins; Lawrence Steinman; Paul J Utz; Peggy P Ho
Journal:  Autoimmunity       Date:  2010-03       Impact factor: 2.815

Review 7.  Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.

Authors:  Wei Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-14       Impact factor: 4.733

8.  Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.

Authors:  Mark Rutz; Jochen Metzger; Tanja Gellert; Peter Luppa; Grayson B Lipford; Hermann Wagner; Stefan Bauer
Journal:  Eur J Immunol       Date:  2004-09       Impact factor: 5.532

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

Authors:  Christina M Lau; Courtney Broughton; Abigail S Tabor; Shizuo Akira; Richard A Flavell; Mark J Mamula; Sean R Christensen; Mark J Shlomchik; Gregory A Viglianti; Ian R Rifkin; Ann Marshak-Rothstein
Journal:  J Exp Med       Date:  2005-10-31       Impact factor: 14.307

View more
  13 in total

1.  FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4+ T Cells.

Authors:  Anil K Chauhan
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

2.  FcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression.

Authors:  Anil K Chauhan; Terry L Moore; Ye Bi; Chen Chen
Journal:  J Biol Chem       Date:  2015-11-18       Impact factor: 5.157

3.  Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations.

Authors:  De Azevêdo Silva J; Addobbati C; Sandrin-Garcia P; Crovella S
Journal:  Curr Genomics       Date:  2014-02       Impact factor: 2.236

4.  The role of disease activity score 28 in the evaluation of articular involvement in systemic lupus erythematosus.

Authors:  Fulvia Ceccarelli; Carlo Perricone; Laura Massaro; Viviana Antonella Pacucci; Enrica Cipriano; Simona Truglia; Francesca Miranda; Francesca Romana Spinelli; Cristiano Alessandri; Guido Valesini; Fabrizio Conti
Journal:  ScientificWorldJournal       Date:  2014-11-03

5.  Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus.

Authors:  Fabrizio Conti; Fulvia Ceccarelli; Giancarlo Iaiani; Carlo Perricone; Alessandra Giordano; Luigino Amori; Francesca Miranda; Laura Massaro; Viviana Antonella Pacucci; Simona Truglia; Gabriella Girelli; Azis Fakeri; Gloria Taliani; Chiara Temperoni; Francesca Romana Spinelli; Cristiano Alessandri; Guido Valesini
Journal:  Arthritis Res Ther       Date:  2016-07-30       Impact factor: 5.156

6.  Kidney Expression of Toll Like Receptors in Lupus Nephritis: Quantification and Clinicopathological Correlations.

Authors:  Fabrizio Conti; Francesca Romana Spinelli; Simona Truglia; Francesca Miranda; Cristiano Alessandri; Fulvia Ceccarelli; Michele Bombardieri; Konstantinos Giannakakis; Guido Valesini
Journal:  Mediators Inflamm       Date:  2016-08-21       Impact factor: 4.711

7.  A meta-analysis of public microarray data identifies gene regulatory pathways deregulated in peripheral blood mononuclear cells from individuals with Systemic Lupus Erythematosus compared to those without.

Authors:  Wendy Kröger; Darlington Mapiye; Jean-Baka Domelevo Entfellner; Nicki Tiffin
Journal:  BMC Med Genomics       Date:  2016-11-15       Impact factor: 3.063

Review 8.  Staphylococcus aureus Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and Phenotype.

Authors:  Fulvia Ceccarelli; Carlo Perricone; Giulio Olivieri; Enrica Cipriano; Francesca Romana Spinelli; Guido Valesini; Fabrizio Conti
Journal:  Int J Mol Sci       Date:  2019-11-11       Impact factor: 5.923

9.  Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.

Authors:  Fabrizio Conti; Fulvia Ceccarelli; Laura Massaro; Viviana A Pacucci; Francesca Miranda; Simona Truglia; Enrica Cipriano; Francesco Martinelli; Ilaria Leccese; Francesca Romana Spinelli; Cristiano Alessandri; Carlo Perricone; Guido Valesini
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

10.  High prevalence of antinuclear antibodies in children with thyroid autoimmunity.

Authors:  Maria Segni; Ida Pucarelli; Simona Truglia; Ilaria Turriziani; Chiara Serafinelli; Fabrizio Conti
Journal:  J Immunol Res       Date:  2014-02-24       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.